Imunon sells rights to ThermoDox to VoxelDox
Imunon is divesting ThermoDox rights to VoxelDox for up to $16.5 million and royalties to fund its core IMNN-001 program, reinforcing capital allocation strategy.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed